What is the significance of extended spectrum betalactamases in clinical practice?
Vora, S.; Auckenthaler, R.
Revue Medicale Suisse 5(220): 1991-1994
2009
ISSN/ISBN: 1660-9379 PMID: 19908639 Document Number: 16080
Extended spectrum betalactamases (ESBL) confer resistance to most commonly used betalactam antibiotics. Their emergence in Gram negative bacteria was observed after the widespread use of cephalosporins and quinolones. They can cause severe infections in the hospital as well as in the community. Carbapenems remain the first choice of treatment for these infections. Appropriate use of antibiotics could decrease the spread of ESBLs.
Document emailed within 1 workday
Related Documents
Chlebicki, M.P.; Oh, H.M.L. 2004: Extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella spp. in a Singapore hospital: clinical spectrum Annals of the Academy of Medicine Singapore 33(3): 302-306Ali, A.M.; Rafi, S.; Qureshi, A.H. 2004: Frequency of extended spectrum beta lactamase producing gram negative bacilli among clinical isolates at clinical laboratories of Army Medical College, Rawalpindi Journal of Ayub Medical College Abbottabad: Jamc 16(1): 35-37
Bradford, P.A.; Jacobus, N.V.; Bhachech, N.; Bush, K. 1996: TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases Antimicrobial Agents and ChemoTherapy 40(1): 260-262
Udomsantisuk, N.; Nunthapisud, P.; Tirawatanapong, T.; Dansuputra, M. 2011: Molecular characterization of extended spectrum beta-lactamase among clinical isolates Escherichia coli and Klebsiella pneumoniae Journal of the Medical Association of Thailand 94(12): 1504-1512
Kusum, M.; Wongwanich, S.; Dhiraputra, C.; Pongpech, P.; Naenna, P. 2004: Occurrence of extended-spectrum beta-lactamase in clinical isolates of Klebsiella pneumoniae in a University Hospital, Thailand Journal of the Medical Association of Thailand 87(9): 1029-1033
Hori, J.; Yamaguchi, S.; Osanai, H.; Kinebuchi, T.; Usami, K.; Takahashi, N.; Ishii, Y. 2007: Clinical study of the urinary tract infections due to Escherichia coli harboring extended-spectrum beta lactamase Hinyokika Kiyo. Acta Urologica Japonica 53(11): 777-782
Ekşi, F.; Ozer, G.ön.ç; Balci, I. 2007: Investigation of the frequency of extended spectrum beta-lactamases and antibiotic resistance in clinical isolates of Escherichia coli and Klebsiella sp Mikrobiyoloji Bulteni 41(3): 447-452
She, D.; Liu, Y. 2002: The expression of AmpC and extended-spectrum beta-lactamases among clinical isolates of enterobacter cloacae and its impact on antibiotics susceptibility Zhonghua Yi Xue Za Zhi 82(19): 1355-1358
González Mesa, L.; Ramos Morí, A.; Nadal Becerra, L.; Morffi Figueroa, J.; Hernández Robledo, E.; Alvarez, A.B.; Marchena Bequer, J.J.; González Alemán, M.; Villain Plous, C. 2007: Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals Revista Cubana de Medicina Tropical 59(1): 52-58
Akpaka, P.E.; Legall, B.; Padman, J. 2010: Molecular detection and epidemiology of extended-spectrum beta-lactamase genes prevalent in clinical isolates of Klebsiella pneumoniae and e coli from Trinidad and Tobago West Indian Medical Journal 59(6): 591-596
Malhotra, V.L.; Khandpur, N.; Dass, A.; Mehta, G. 2008: Prevalence of extended spectrum beta-lactamases producing clinical isolates from patients of urinary tract infection in a tertiary care hospital in Delhi Journal of Communicable Diseases 40(4): 269-272
Wu, J.P.; Pickle, S. 2014: Extended use of the intrauterine device: a literature review and recommendations for clinical practice Contraception 89(6): 495-503
Maseri, A. 1978: Prinzmetal's angina. its clinical significance in the spectrum of ischemic heart diseases Medizinische Klinik 73(47): 1643-1647
Mulualem, Y.; Kasa, T.; Mekonnen, Z.; Suleman, S. 2012: Occurrence of extended spectrum beta (b)-lactamases in multi-drug resistant Escherichia coli isolated from a clinical setting in Jimma University Specialized Hospital, Jimma, southwest Ethiopia East African Journal of Public Health 9(2): 58-61
Luca, C.; Ivan, V.; Moga, V.; Luca, C.T.; Streian, C. 1996: Complete atrioventricular block in patients with acute inferior myocardial infarction. Clinical spectrum and prognostic significance Romanian Journal of Internal Medicine 34(3-4): 189-198
Dandekar, P.K.; Quintiliani, R.; Nightingale, C.H.; Nicolau, D.P. 2002: Extended-spectrum beta-lactamases (ESBL) Connecticut Medicine 66(1): 13-15
Iyobe, S. 1997: Appearance of extended-spectrum beta-lactamases Nihon Rinsho. Japanese Journal of Clinical Medicine 55(5): 1219-1224
Hansen, D.S.; Sirot, D.; Kolmos, H.J. 1998: Extended spectrum beta-lactamases in Danish Klebsiella isolates Ugeskrift for Laeger 160(15): 2261-2262
Lautenbach, E.; Fishman, N.O. 1999: Control of outbreaks due to organisms producing extended-spectrum beta-lactamases JAMA 281(12): 1080-1081
Thabaut, A.; Meyran, M.; Sofer, L.; Morand, A.; Labia, R. 1994: Interactions of ceftibuten with extended-spectrum beta-lactamases: a bacteriological and enzymatic analysis Drugs under Experimental and Clinical Research 20(2): 49-54